Skip to main content
SpringerLink
Log in

Chemical Superficial Vein Ablation

  • Chapter
  • First Online:
Phlebology, Vein Surgery and Ultrasonography

  • 1486 Accesses

Abstract

Sclerotherapy plays a fundamental role for nearly all patients in returning their legs to a healthier state: from the young female patient who comes to the practice with a few telangiectasias to the older patient with severe chronic venous insufficiency, leg ulcers, and resulting limited physical activities and whether using dilute liquid sclerotherapy for those tiny telangiectasias or ultrasound-guided foam sclerotherapy (UGFS) for the large incompetent truncal veins, tributaries, and perforators. Of the many patients presenting with telangiectasias to a phlebology practice and professing cosmetic concerns, only about 20 % will be found to have purely “cosmetic” vein problems once they are thoroughly screened and undergo duplex scanning. The others will have underlying venous incompetence contributing to the appearance of the telangiectasias, to a greater or lesser extent, and will require correction of the underlying venous disorder prior to sclerotherapy to treat the telangiectasias. This chapter discusses chemical ablation of superficial veins.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Goldman MP. Sodium tetradecyl sulfate for sclerotherapy treatment of veins: is compounding pharmacy solution safe? Dermatol Surg. 2004;30:1–3.

    Article  Google Scholar 

  2. Weiss R, et al. Absence of concentration congruity in six compounded polidocanol samples obtained for leg sclerotherapy. Dermatol Surg. 2011;37:812–5.

    Article  PubMed  CAS  Google Scholar 

  3. Yamaki T, Nozaki M, Sasaki K. Color duplex-guided sclerotherapy for the treatment of venous malformation. Dermatol Surg. 2000;26:323–8.

    Article  PubMed  CAS  Google Scholar 

  4. Ricci S, Georgiev M, Jawien A, Zamboni P. Sciatic nerve varices. Eur J Vasc Endovasc Surg. 2005;29:83–7.

    Article  PubMed  CAS  Google Scholar 

  5. Tessari L. Foam Sclerotherapy Alcock Channel (P point) in pelvic varicose veins. In: 14th annual congress, Melbourne, Australia. Australasian College of Phlebology. 2011.

    Google Scholar 

  6. Carod-Artal FJ, et al. Prevalence of patent foramen ovale in migraine patients with and without aura compared with stroke patients. A transcranial Doppler study. Cephalalgia. 2006;26:934–9.

    Article  PubMed  CAS  Google Scholar 

  7. Ouvrey P, et al. Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: a multicentre randomised controlled trial with a two-year follow up. Eur J Vasc Endovasc Surg. 2008;36(3):366–70.

    Article  Google Scholar 

  8. Rabe E, Otto J, Schliephake D, Pannier F. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial. Eur J Vasc Endovasc Surg. 2008;35:238–45.

    Article  PubMed  CAS  Google Scholar 

  9. Wright D, Gobin JP, Bradbury AW, et al. Varisolve® polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial. Phlebology. 2006;21:180–90.

    Article  Google Scholar 

  10. Rasmussen L, et al. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Br J Surg. 2011;98:1079–87.

    Article  PubMed  CAS  Google Scholar 

  11. Hamel-Desnos C, Desnos P, Wollmann JC, Ouvry P, Mako S, Allaert FA. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg. 2003;19(12):1170–5.

    Article  Google Scholar 

  12. Coleridge Smith P. Saphenous ablation: sclerosant or sclerofoam? Semin Vasc Surg. 2005;18(1):19–24.

    Article  PubMed  Google Scholar 

  13. Yamaki T, Nozaki M, Iwasaka S. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol Surg. 2004;30:718–22.

    Article  PubMed  Google Scholar 

  14. Jia X, Mowat G, Burr JM, Cassar K, Cook J, Fraser C. Systematic review of foam sclerotherapy for varicose veins. Br J Surg. 2007;94:925–36.

    Article  PubMed  CAS  Google Scholar 

  15. Tessari L. Nouvelle technique d’obtention de la sclero-mousse. Phlebologie. 2000;53:129.

    Google Scholar 

  16. Morrison N, Neuhardt DL, Rogers CR, McEown J, Morrison T, Johnson E, Salles-Cunha SX. Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vasc Surg. 2008;47:830–6.

    Article  PubMed  Google Scholar 

  17. Morrison N. Foam sclerotherapy: how to improve results and reduced side effects. Phlebologie. 2008;37:211–20.

    Google Scholar 

  18. Cavezzi A, Tessari L. Foam sclerotherapy techniques: different gases and methods of preparation, catheter versus direct injection. Phlebology. 2009;24:247–51.

    Article  PubMed  CAS  Google Scholar 

  19. Hamel-Desnos C, et al. Échosclerotherapie a la Mouse par Ponction-Injection Directe aL’Aiguille: Technique et Doses. J Mal Vasc. 2006;31(4):180–9.

    Google Scholar 

  20. Cabrera J, Cabrera Jr J, Garcia-Olmedo MA, Redondo P. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol. 2003;139:1409–16.

    Article  PubMed  Google Scholar 

  21. Cabrera J, Cabrera Jr J, Garcia-Olmedo MA. Treatment of varicose long saphenous veins with sclerosant in microfoam form: long term outcomes. Phlebology. 2000;15:19–23.

    Article  Google Scholar 

  22. Myers KA, Jolley D, Clough A, Kirwan J. Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance. Eur J Vasc Endovasc Surg. 2007;33:116–21.

    Article  PubMed  CAS  Google Scholar 

  23. Frullini A, Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectasias: history and analysis of safety and complications. Dermatol Surg. 2002;28:11–5.

    Article  PubMed  Google Scholar 

  24. Smith PC. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Endovasc Surg. 2006;32:577–83.

    Article  PubMed  Google Scholar 

  25. Darvall K, et al. Duplex ultrasound outcomes following ultrasound-guided foam sclerotherapy of symptomatic primary great saphenous varicose veins. Eur J Vasc Endovasc Surg. 2010;40:534–9.

    Article  PubMed  CAS  Google Scholar 

  26. Stucker M, et al. Review of published information on foam sclerotherapy. Dermatol Surg. 2010;36:983–92.

    Article  PubMed  Google Scholar 

  27. De Maeseneer M, Pichot O, Cavezzi A, Earnshaw J, van Rij A, Lurie F, Coleridge Smith P. Duplex ultrasound investigation of the veins of the lower limbs after treatment for varicose veins – UIP consensus document. Eur J Vasc Endovasc Surg. 2011;42(1):89–102.

    Article  PubMed  Google Scholar 

  28. Fegan WG. Injection with compression as a treatment for varicose veins. Proc R Soc Med. 1965;58:874–6.

    PubMed  CAS  Google Scholar 

  29. McAree B, et al. Comparative stability of sodium tetradecyl sulphate (STD) and polidocanol foam: impact on vein damage in an in-vitro model. Eur J Vasc Endovasc Surg 2012;43:721–725.

    Google Scholar 

  30. Wollman JC. Sclerosant foams: stabilities, physical properties and rheological behavior. Phlebologie. 2010;39:208–17.

    Google Scholar 

  31. Eckmann DM, Kobayashi S, Li M. Microvascular embolization following polidocanol microfoam sclerosant administration. Dermatol Surg. 2005;31:636–64.

    Article  PubMed  CAS  Google Scholar 

  32. Bhogal RH, et al. Can foam sclerotherapy be used to safely treat bilateral varicose veins? Phlebology. 2012;27(1):19–24..

    Google Scholar 

  33. Parsi K. Catheter-directed sclerotherapy. Phlebology. 2009;24:98–107.

    Article  PubMed  CAS  Google Scholar 

  34. Bergan J, Pascarella L, Mekenas L. Venous disorders: treatment with sclerosant foam. J Cardiovasc Surg (Torino). 2006;47:9–18.

    CAS  Google Scholar 

  35. Hamel-Desnos C, Ouvry P, Benigni J-P, Boitelle G, Schadeck M, Desnos P, Allaert F-A. Comparison of 1 % and 3 % polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. “The 3/1 study”. Eur J Vasc Endovasc Surg. 2007;20:1–7.

    Google Scholar 

  36. Ceulen RP, Bullens-Goessens YI, Pi-VAN de Venne SJ, Nelemans PJ, Veraart JC, Sommer A. Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1 % versus 3 % polidocanol foam: results of a randomized controlled trial with 1-year follow-up. Dermatol Surg. 2007;33:276–81.

    Article  PubMed  CAS  Google Scholar 

  37. Wollman JC. The history of sclerosing foams. Dermatol Surg. 2004;30:694–703.

    Article  Google Scholar 

  38. Van Deurzen B, Ceulen R, et al. Polidocanol concentration and time affect the properties of foam used for sclerotherapy. Dermatol Surg. 2011;37:1448–55.

    Article  Google Scholar 

  39. Ceulen R, et al. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med. 2008;35:8–14.

    Google Scholar 

  40. Forlee MV, Grouden M, Moore DJ, Shanik G. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg. 2006;43:162–4.

    Article  PubMed  Google Scholar 

  41. Guex JJ, et al. The French polidocanol study on long-term side effects: a survey covering 3,357 patient years. Dermatol Surg. 2010;36:993–1003.

    Article  PubMed  CAS  Google Scholar 

  42. Regan J, et al. Clinical significance of cerebrovascular gas emboli during polidocanol endovenous ultra-low nitrogen microfoam ablation and correlation with magnetic resonance imaging in patients with right-to-left shunts. J Vasc Surg. 2011;53:131–8.

    Article  PubMed  Google Scholar 

  43. Gillet J-L, et al. Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients. Phlebology. 2009;24:131–8.

    Article  PubMed  Google Scholar 

  44. Morrison N, et al. Incidence of side effects using carbon dioxide-oxygen foam for chemical ablation of superficial veins of the lower extremity. Eur J Vasc Endovasc Surg. 2010;40:407–13.

    Article  PubMed  CAS  Google Scholar 

  45. Wright DD. High prevalence of right-to-left shunt in patients with symptomatic great saphenous incompetence and varicose veins. J Vasc Surg. 2010;51:104–7.

    Article  PubMed  Google Scholar 

  46. Neuhardt D. Incidence of deep vein thrombosis in a duplicated femoral vein following Foam USG of the GSV. Abstract: first days of phlebology. Parma. 2006.

    Google Scholar 

  47. Myers K, Jolley D. Factors affecting the risk of deep venous occlusion after ultrasound-guided sclerotherapy for varicose veins. Eur J Vasc Endovasc Surg. 2008;20:1–4.

    Google Scholar 

  48. Parsi K, et al. In vitro effects of detergent sclerosants on coagulation, platelets and microparticles. Eur J Vasc Endovasc Surg. 2007;34:731–40.

    Article  PubMed  CAS  Google Scholar 

  49. Parsi K, et al. The lytic effects of detergent sclerosants on erythrocytes, platelets, endothelial cells and microparticles are attenuated by albumin and other plasma components in vitro. Eur J Vasc Endovasc Surg. 2008;36:216–23.

    Article  PubMed  CAS  Google Scholar 

  50. Hamel-Desnos C, Desnos P, et al. In vivo biological effects of foam sclerotherapy. Eur J Vasc Endovasc Surg. 2011;42(2):238–45.

    Article  PubMed  CAS  Google Scholar 

  51. Hamel-Desnos C, Gillet J-L, Desnos P, Allaert F. Sclerotherapy of varicose veins in patients with documented thrombophilia: a prospective controlled randomized study of 105 cases. Phlebology. 2009;24:176–82.

    Article  PubMed  CAS  Google Scholar 

  52. Thomasset SC, et al. Ultrasound guided foam sclerotherapy: factors associated with outcomes and complications. Eur J Vasc Endovasc Surg. 2010;40:389–92.

    Article  PubMed  CAS  Google Scholar 

  53. Bush RG, Derrick M, Manjoney D. Major neurological events following foam sclerotherapy. Phlebology. 2008;23:189–92.

    Article  PubMed  CAS  Google Scholar 

  54. Ma RWL, Parsi K, et al. Three cases of stroke following peripheral venous interventions. Phlebology 2011;26:280–4.

    Google Scholar 

  55. Breu FX, Guggenbichler S. 2nd European consensus meeting on foam sclerotherapy. Tegernsee, Germany. VASA. Eur J Vasc Med 2008;37:S37–71.

    Google Scholar 

  56. Hanisch F, Müller T, Krivokuca M, Winterholler W. Stroke following variceal sclerotherapy. Eur J Med Res. 2004;9:282–4.

    PubMed  Google Scholar 

  57. Caggiati A, Franceschini M. Stroke following endovenous laser treatment of varicose veins. J Vasc Surg. 2010;51:218–20.

    Article  PubMed  Google Scholar 

  58. Harzheim M, Becher H, Klockgether T. Brain infarct from a paradoxical embolism following a varices operation. Dtsch Med Wochenschr. 2000;125:794–6.

    Article  PubMed  CAS  Google Scholar 

  59. Morrison N. Studies on safety of foam sclerotherapy. In: Bergan JJ, Chang V, editors. Foam sclerotherapy. London: Royal Society of Medicine Press Ltd; 2008.

    Google Scholar 

  60. Gillet JL, et al. Pathophysiology of visual disturbances occurring after foam sclerotherapy. Phlebology. 2010;25:261–6.

    Article  PubMed  CAS  Google Scholar 

  61. McCandless RT, et al. Patent foramen ovale in children with migraine headaches. J Pediatr. 2011;159(2):243–7.

    Article  PubMed  Google Scholar 

  62. Bradbury A, et al. Ultrasound-guided foam sclerotherapy is a safe and clinically effective treatment for superficial venous reflux. J Vasc Surg. 2010;52(4):939–45.

    Article  PubMed  Google Scholar 

  63. Wright D, et al. Polidocanol microfoam does not cause remote sclerosis in the lung. Poster presentation: ACP 23rd annual congress. Palm Desert. Nov 2008.

    Google Scholar 

  64. Broderson JP, Geismar U. Catheter-assisted vein sclerotherapy: a new approach for sclerotherapy of the greater saphenous vein with a double-lumen balloon catheter. Dermatol Surg. 2007;33:469–75.

    Article  Google Scholar 

  65. Kolbeln T, Hinchliffe R, Lindbladn B. Catheter-directed foam sclerotherapy of axial saphenous reflux: early results. Phlebology. 2007;22:219–22.

    Article  Google Scholar 

  66. Parsi K. Venous gas embolism during foam sclerotherapy of saphenous veins despite recommended treatment modifications. Phlebology. 2011;26:140–7.

    Article  PubMed  CAS  Google Scholar 

  67. Hill D, et al. Assessment of techniques to reduce sclerosant foam migration during ultrasound-guided sclerotherapy of the great saphenous vein. J Vasc Surg. 2008;48:934–9.

    Article  PubMed  Google Scholar 

  68. Ceulen R, et al. Blocking the saphenofemoral junction during ultrasound-guided foam sclerotherapy: assessment of a presumed safety-measure procedure. Eur J Vasc Endovasc Surg. 2010;40:772–6.

    Article  PubMed  CAS  Google Scholar 

  69. Yamaki T, et al. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins. Eur J Vasc Endovasc Surg. 2009;37(3):343–8.

    Article  PubMed  CAS  Google Scholar 

  70. Morrison N, Neuhardt D. Foam sclerotherapy: cardiac and cerebral monitoring. Phlebology. 2009;00:1–8.

    CAS  Google Scholar 

  71. Tessari L, Cavezzi A, Rosso M, Cabrera Garrido A. Variables in foam sclerotherapy: literature and experimental data. Aust NZ J Phlebol. 2008;11(1):83–4.

    Google Scholar 

  72. Gillet J-L. Neurological complications of foam sclerotherapy: fears and reality. Phlebology. 2011;26:277–9.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The author gratefully acknowledges the contribution of Diana Neuhardt, RVT, of Compudiagnostics for her clinical assistance and provision of the excellent duplex images in this manuscript, as well as editing assistance provided by Adrienne Travis and Denise Bork.

Author information

Authors and Affiliations

  1. Morrison Vein Institute, Scottsdale, AZ, USA

    Nick Morrison MD, FACPh, FACS, RPhS

Authors
  1. Nick Morrison MD, FACPh, FACS, RPhS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nick Morrison MD, FACPh, FACS, RPhS .

Editor information

Editors and Affiliations

  1. Vein Specialists of Monterey, Monterey, California, USA

    Eric Mowatt-Larssen

  2. Department of Surgery, University of Texas-Houston Duke University School of Medicine, Houston, Texas, USA

    Sapan S. Desai

  3. MSB 5.030, University of Texas-Houston, Houston, Texas, USA

    Anahita Dua

  4. Vascular Surgery, Duke University Medical Center, Durham, North Carolina, USA

    Cynthia E. K. Shortell

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Morrison, N. (2014). Chemical Superficial Vein Ablation. In: Mowatt-Larssen, E., Desai, S., Dua, A., Shortell, C. (eds) Phlebology, Vein Surgery and Ultrasonography. Springer, Cham. https://doi.org/10.1007/978-3-319-01812-6_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-01812-6_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-01811-9

  • Online ISBN: 978-3-319-01812-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation